Finally, the altered senescence profile observed in CD4 T cells, CD8 T cells, and monocytes of older adults with MDD suggests that targeting cellular senescence pathways in immune cells could be a potential avenue for therapeutic intervention in MDD. Here, CD8A is linked to major depressive disorder.